Market Share of Biologics Industry
The biologics market is moderately competitive and consists of several major players. The companies are implementing certain strategic initiatives such as mergers, new product launches, acquisitions, and partnerships that help them strengthen their market positions. These companies have made huge capital investments in the research and development of biologics, as the cost of biologics is quite high.
Biologics Market Leaders
Amgen, Inc.
Eli Lilly and Company
GlaxoSmithKline PLC
Abbvie Inc.
F. Hoffmann- La Roche AG
*Disclaimer: Major Players sorted in no particular order
